The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System in October 2024.
As competition intensifies among surgical robot makers, CMR said its soft tissue platforms are the second most used systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback